SB 614 Virginia Senate · 2024 Regular Session

Xylazine; penalty for manufacturing, selling, etc., for human consumption.

Summary
Xylazine; manufacturing; selling; giving; distributing; possessing; veterinary use exemption; penalties. Provides that any person who knowingly manufactures, sells, gives, distributes, or possesses with the intent to manufacture, sell, give, or distribute the substance xylazine, when intended for human consumption, is guilty of a Class 5 felony. Under the bill, any person who knowingly possesses xylazine, when intended for human consumption, is guilty of a Class 1 misdemeanor. Under the bill, it is not an offense to (i) manufacture xylazine for legitimate veterinary use; (ii) distribute or sell xylazine for authorized veterinary use; (iii) possess, administer, prescribe, or dispense xylazine in good faith for use by animals within the course of legitimate veterinary practice; or (iv) possess or administer xylazine pursuant to a valid prescription from a licensed veterinarian. This bill is identical to HB 1187.
Bill status signed all 5 stages cleared
Introduction
Jan 2024
Committee Review
Feb 2024
Senate Passage
Mar 2024
House of Delegates Passage
Feb 2024
Signed into Law
Apr 2024
Introduced Jan 10, 2024 Signed Apr 4, 2024
Floor votes · Senate Feb 9, 2024 · House of Delegates Feb 26, 2024

How they voted

40–0
Passed
Total votes 40
Feb 9, 2024
D Democratic21
21 Yea
100% Yea
R Republican19
19 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
40
Key actions
7
Committee
12
Apr 4, 2024
Signed into law
Approved by Governor-Chapter 516 (effective 7/1/24)
Mar 3, 2024
Senate · Passed
Signed by President
Feb 29, 2024
House of Delegates · Passed
Signed by Speaker
Feb 29, 2024
Senate · Passed
Bill text as passed Senate and House (SB614ER)
Feb 26, 2024
House of Delegates · Passed
VOTE: Block Vote Passage (96-Y 0-N)
Feb 26, 2024
House of Delegates · Passed
Passed House BLOCK VOTE (96-Y 0-N)
Feb 21, 2024
House of Delegates · Reported by committee
Reported from Appropriations (22-Y 0-N)
Feb 16, 2024
House of Delegates · Referred to committee
Referred to Committee on Appropriations
Feb 16, 2024
House of Delegates · Reported by committee
Reported from Courts of Justice (22-Y 0-N)
Feb 15, 2024
House of Delegates · Referred to committee
Referred to Committee for Courts of Justice
Feb 9, 2024
Senate · Passed
Passed Senate (40-Y 0-N)
Feb 7, 2024
Senate · Reported by committee
Reported from Finance and Appropriations (15-Y 0-N)
Feb 5, 2024
Senate · Referred to committee
Rereferred to Finance and Appropriations
Feb 5, 2024
Senate · Reported by committee
Reported from Courts of Justice (15-Y 0-N)
Feb 1, 2024
Senate · Referred to committee
Rereferred to Courts of Justice
Feb 1, 2024
Senate · Reported by committee
Reported from Education and Health with substitute (15-Y 0-N)
Jan 26, 2024
Senate · Reported by committee
Senate subcommittee amendments and substitutes offered
Jan 16, 2024
Senate · Referred to committee
Assigned Education and Health Sub: Health Professions
Jan 10, 2024
Senate · Referred to committee
Referred to Committee on Education and Health
1 primary · 1 co-sponsor

Sponsors